POSITRIGO

Imaging Everyone

Zurich, Switzerland · Founded 2018 · $15.6M raised

Headquarters
Zurich
Employees
11–50
Founded
2018
Business Model
B2B
Total Funding
$15.6M
Last Round
$8.7M Venture RoundJun 2025
Rounds
2

About

Positrigo, headquartered in Zurich, Switzerland, was founded in 2018 as a spin-off of ETH Zurich. The company develops NeuroLF, an ultra-compact, dedicated brain Positron Emission Tomography (PET) scanner that makes functional brain imaging accessible for diagnosing Alzheimer's disease, dementia, neuro-oncology, epilepsy, and movement disorders. NeuroLF has received both FDA clearance and CE Mark, and Positrigo has expanded into the U.S. and multiple European markets.

Summary

POSITRIGO is a Biotech company based in Zurich, Switzerland, founded in 2018. It has raised $15.6M in total across 2 rounds, most recently a $8.7M Venture Round round in Jun 2025. Investors include HealthCap, EIC Fund and Zürcher Kantonalbank.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFinancing RoundJun 2025
$8.7M

Sign up to see all 2 rounds

Series B through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

POSITRIGO on Indexed.vc
<a href="https://indexed.vc/companies/positrigo"><img src="https://indexed.vc/api/badge/company/positrigo" alt="POSITRIGO on Indexed.vc" width="260" height="76" /></a>